Evidence map›Paper›PMID 33772947›Full record

Trial reportAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2021

Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy.

Arwa Younis, Mehmet K Aktas, Wojciech Zareba, Scott McNitt, Valentina Kutyifa, Ilan Goldenberg

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Predicting Ventricular Tachyarrhythmias in Patients With Left Ventricular Ejection Fraction Improvement Following Cardiac Resynchronization Therapy.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2025
    Trial
  2. Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2021
    Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Arwa YounisClinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-2485-5025
Mehmet K AktasClinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.
Wojciech ZarebaClinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.
Scott McNittClinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.
Valentina KutyifaClinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-0016-289X
Ilan GoldenbergClinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · US

Funding

Boston Scientific Corporation
6 · The paper itself

Abstract

introductionCardiac resynchronization therapy (CRT) may be pro-arrhythmic in patients with non-left bundle branch block (non-LBBB). We hypothesized that combined assessment of risk factors (RF) for ventricular tachyarrhythmias (VTAs) can be used to stratify non-LBBB patients for CRT implantation.

methodsThe study comprised 412 non-LBBB patients from MADIT-CRT randomized to CRT-D (n = 215) versus ICD only (n = 197). Best-subset regression analysis was performed to identify RF associated with increased VTA risk in CRT-D patients without LBBB. The primary end point was first occurrence of sustained VTA during follow-up. Secondary end points included VTA/death and appropriate shock.

resultsFour RFs were associated with increased VTA risk: blood urea nitrogen >25mg/dl, ejection fraction <20%, prior nonsustained VT, and female gender. Among CRT-D patients, 114 (53%) had no RF, while 101 (47%) had ≥1 RF. The 4-year cumulative probability of VTA was higher among those with ≥1 RF compared with those without RF (40% vs. 14%, p < .001). Multivariate analysis showed that in patients without RF, treatment with CRT-D was associated with a 61% reduction in VTA compared with ICD-only therapy (p = .002), whereas among patients with ≥1 RF, treatment with CRT-D was associated with a corresponding 73% (p = .025) risk increase. Consistent results were observed when the secondary end points of VTA/death and appropriate ICD shocks were assessed.

conclusionCombined assessment of factors associated with increased risk for VTA can be used for improved selection of non-LBBB patients for CRT-D.

Indexed as

Cardiac Resynchronization TherapyDefibrillators, ImplantableHeart FailureTachycardia, VentricularBundle-Branch BlockElectrocardiographyFemaleHumansRisk FactorsTreatment Outcomecardiac resynchronization therapynon-left bundle branch blockpro-arrhythmic effectrisk factorsventricular tachycardia

Identifiers

PMID33772947
PMCPMC8293612
OpenAlexW3152017990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.